跳至主要内容
临床试验/NCT03136263
NCT03136263已完成早期 1 期

Effects of Oxytocin on Cognitive Control in Adults With Attention Deficit/Hyperactivity Disorder

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2017年12月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
24
试验地点
1
主要终点
Stop-signal task

研究概览

简要总结

This is a randomized, double-blind, placebo-controlled crossover study of single-dose intranasal oxytocin (24 IU) in 18-55 year-old men with attention deficit/hyperactivity disorder (ADHD). Following a screening visit to determine eligibility, participants will return for two main study visits. During the main study visits, study participants will receive either oxytocin (Syntocinon® nasal spray, Victoria Pharmacy, Zürich, Switzerland) or placebo (inactive ingredients of Syntocinon® nasal spray, Victoria Pharmacy), followed by assessments of cognitive control over attention and behavior. Twenty-four participants will be randomized 1:1 to one of two drug orders, i.e., oxytocin - placebo or placebo - oxytocin. In an additional neuroimaging substudy, a subset of participants will undergo task-based and resting-state functional magnetic resonance imaging (fMRI) following oxytocin/placebo administration to investigate the effects of oxytocin on fMRI activation and functional connectivity within the cognitive control network.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Drug order: Oxytocin - placebo

Experimental

干预措施: Oxytocin nasal spray (Drug)

Drug order: Oxytocin - placebo

Experimental

干预措施: Placebo nasal spray (Drug)

Drug order: Placebo - oxytocin

Experimental

干预措施: Oxytocin nasal spray (Drug)

Drug order: Placebo - oxytocin

Experimental

干预措施: Placebo nasal spray (Drug)

结局指标

主要结局

Stop-signal task

时间窗: First and second main study visits (1-4 weeks apart)

Mean difference in performance on the stop-signal task between the oxytocin and placebo visits (e.g., stop-signal reaction time)

次要结局

  • AX-CPT(First and second main study visits (1-4 weeks apart))
  • Category switch task(First and second main study visits (1-4 weeks apart))
  • Global/local task(First and second main study visits (1-4 weeks apart))
  • Simon task(First and second main study visits (1-4 weeks apart))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elizabeth Austen Lawson

Assistant Professor of Medicine, Harvard Medical School

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验

Oxytocin and Cognitive Control in Adult ADHD | 临床试验